Your browser doesn't support javascript.
loading
Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries.
Vallersnes, Odd Martin; Dines, Alison M; Wood, David M; Heyerdahl, Fridtjof; Hovda, Knut Erik; Yates, Christopher; Giraudon, Isabelle; Caganova, Blazena; Ceschi, Alessandro; Galicia, Miguel; Liakoni, Evangelia; Liechti, Matthias E; Miró, Òscar; Noseda, Roberta; Persett, Per Sverre; Põld, Kristiina; Schmid, Yasmin; Scholz, Irene; Vigorita, Federico; Dargan, Paul I.
Afiliação
  • Vallersnes OM; Department of General Practice, University of Oslo, PB 1130, Blindern, Oslo, 0318, Norway. o.m.vallersnes@medisin.uio.no.
  • Dines AM; Oslo Accident and Emergency Outpatient Clinic, City of Oslo Health Agency, Oslo, Norway. o.m.vallersnes@medisin.uio.no.
  • Wood DM; Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
  • Heyerdahl F; Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
  • Hovda KE; Clinical Toxicology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Yates C; Prehospital Division, Oslo University Hospital, Oslo, Norway.
  • Giraudon I; The Norwegian Air Ambulance Foundation, Oslo, Norway.
  • Caganova B; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Ceschi A; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Galicia M; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
  • Liakoni E; Emergency Department and Clinical Toxicology Unit, Hospital Universitari Son Espases, Palma, Spain.
  • Liechti ME; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
  • Miró Ò; National Toxicological Information Centre, University Hospital, Bratislava, Slovakia.
  • Noseda R; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Persett PS; Emergency Department, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Põld K; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Schmid Y; Clinical Pharmacology and Toxicology, University Hospital and University of Basel, Basel, Switzerland.
  • Scholz I; Emergency Department, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Vigorita F; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
  • Dargan PI; Department of Acute Medicine, Oslo University Hospital, Oslo, Norway.
Int J Emerg Med ; 16(1): 86, 2023 Nov 29.
Article em En | MEDLINE | ID: mdl-38030969
ABSTRACT

BACKGROUND:

Self-discharge is a risk factor for readmission and excess mortality. We assess the rate of self-discharge from the emergency department (ED) among presentations for acute recreational drug toxicity and identify factors associated with self-discharge.

METHODS:

From the Euro-DEN Plus database of presentations to the ED with acute recreational drug toxicity, we extracted data from 11 centres in seven European countries from 2014 to 2017. Self-discharge was defined as taking one's own discharge or escaping from the ED before being medically cleared. We used multiple logistic regression analyses to look for factors associated with self-discharge.

RESULTS:

Among 15,135 included presentations, 1807 (11.9%) self-discharged. Self-discharge rates varied from 1.7 to 17.1% between centres. Synthetic cannabinoids were associated with self-discharge, adjusted odds ratio 1.44 (95% confidence interval 1.10-1.89), as were heroin, 1.44 (1.26-1.64), agitation, 1.27 (1.10-1.46), and naloxone treatment, 1.27 (1.07-1.51), while sedation protected from self-discharge, 0.38 (0.30-0.48).

CONCLUSION:

One in eight presentations self-discharged. There was a large variation in self-discharge rates across the participating centres, possibly partly reflecting different discharge procedures and practices. Measures to improve the management of agitation and cautious administration of naloxone to avoid opioid withdrawal symptoms may be approaches worth exploring to reduce self-discharge.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Emerg Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int J Emerg Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Noruega